The authors stated that this association possibly can be due to the interaction of FGFR2 variants with high levels of endogenous sex hormones (FGFR2 is upregulated in ERα-positive breast tumors) [21], especially estrogens, which may increase breast cancer risk. Here, FGFR2 is linked to breast carcinoma.